NCT00325143View on ClinicalTrials.gov

Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine

PHASE3CompletedINTERVENTIONAL
Enrollment

702

Participants

Timeline

Start Date

December 1, 2003

Primary Completion Date

February 1, 2007

Study Completion Date

February 1, 2007

Conditions
Haemophilus Influenzae Type bDiphtheriaTetanusPoliomyelitisAcellular Pertussis
Interventions
BIOLOGICAL

DTPa-HBV-IPV/Hib

1 intramuscular injection (3rd study vaccine dose)

BIOLOGICAL

DTPa-IPV/Hib vaccine

3 intramuscular injections (1st, 2nd and 4th vaccine dose)

Trial Locations (3)

119074

GSK Investigational Site, Singapore

228510

GSK Investigational Site, Singapore

229899

GSK Investigational Site, Singapore

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY